• Home
  • About Us
  • The History of The Stock Market
  • Profiled Companies
  • Disclaimer
  • Contact Us
  • Subscribe Now!

$PRTN….Eaton Scientific Enters Agreement with RoxSan Pharmacy to Provide Tropine 3 for its upcoming Clinical Trial Participants

Sep05
2012
Leave a Comment Written by THESTOCK411.COM

Eaton Scientific Systems, Ltd. (“Eaton Scientific” or the “Company”), a wholly owned subsidiary of Pristine Solutions, Inc. (PRTN) is pleased to announce that the Company has entered into an agreement with RoxSan Pharmacy Inc. to provide continued specialized compound prescription of Homatropine in a novel oral suspension (“Tropine 3″) to support planned FDA compliant Clinical trial participants.  Tropine 3 is a patent pending novel indication of an existing FDA approved drug for the non-hormonal treatment of hot flashes in pre-menopausal, peri-menopausal, and post-menopausal women.  Details regarding the multi-location multi-phase FDA compliant Tropine 3 clinic trials are expected to be finalized within the next few weeks.

“We feel that the RoxSan Pharmacy team and facilities are uniquely qualified to continually supply the Clinical Trial with the highest-quality custom dosage of and support during our planned FDA compliant clinical trials period that is excepted to dramatically increase localized demand,” stated Michael Borkowski, CEO and President of Eaton Scientific.

RoxSan Pharmacy has over 40 years of experience with a highly-qualified and educated team of pharmacists, technicians, and chemists to custom prepare high-quality compounded and manufactured medications using several unique delivery systems including, but not limited to, lozenges, nasal spray, cream, lotion, or transdermal gel.  RoxSan Pharmacy services are tilized by a variety of health care participants, including new drug developers, dermatologists, plastic surgeons, orthopedic surgeons, and pain care specialists.

Compounding pharmacies provide medications that are individually formulated to meet the patient’s specific health care needs. Custom compounding formulations allows users to quickly and economically modify delivery form, create combination preparations, prescribed specific formulations, and dosage modifications.  Preparation of these specialized products requires chemicals, equipment, and skills that are not available in common pharmacies.

RoxSan Pharmacy is based in Beverly Hills, California and led by the acclaimed doctors Shana Melamed, Pharm.D and son Hootan Melamed, Pharm.D. RoxSan Pharmacy is a member of the Beverly Hills Chamber of Commerce, American Fertility Association, California Pharmacist Association, National Community Pharmacist Association, and the International Academy of Compounding Pharmacies.  Shana Melamed was previously named Beverly Hills Business Woman of The Year in three consecutive years. www.roxsan.com

Share this:

  • Twitter
  • More
  • Facebook
  • Google +1
Posted in Hot Stock Picks, News, Penny Stocks, Pink Sheets, Watchlist - Tagged hot stock picks, PRTN, the stock 411, watch list
SHARE THIS Twitter Facebook Delicious StumbleUpon E-mail
← Oraco Resources, Inc. Announces First Shipment of Rough Diamonds from Sierra Leone
A few to watch today →

No Comments Yet

Leave a Reply Cancel reply

You must be logged in to post a comment.

Sign up today and get the hotest picks before the market does! Don't get left watching the run.

MARKET QUICK VIEW

NASDAQ3498.965  chart +0.97%
S&P 5001667.47  chart +1.03%
EGCT0.101  chart -12.17%
AAPL433.26  chart -0.30%
TAGG0.0121  chart +6.14%
CYOE0.012  chart +9.09%
GOOG909.18  chart +0.59%
PFE28.96  chart -0.99%
CTXS66.84  chart +0.01%
MSFT34.87  chart +2.32%
2013-05-17 17:15

Google News
U.S. : Business

  • Leaning Down: Facebook's Stock At Its IPO Anniversary - Forbes
  • Consumer Sentiment Index in U.S. Rose to 83.7 in May from 76.4 - Bloomberg
  • Will American's New Boarding Process Work? It Failed at Virgin America. - Forbes
  • Tumblr In Talks With Yahoo; Facebook And Microsoft Also Said To Be Circling - Forbes
  • Gains for a 4th Week in a Row, and Milestones, Too - New York Times

Daily Post Research

May 2013
M T W T F S S
« Apr    
 12345
6789101112
13141516171819
20212223242526
2728293031  

TheStock411.com
Your Growth-Focused Investment Blog: Reliable and Educated Stock Tips